Covered recipient · General Payments record
SAMUEL A KAREFF
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2022–2024
$5,057.96
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,070.00 | 1 |
| Food and Beverage | $1,681.49 | 46 |
| Education | $189.94 | 2 |
| Travel and Lodging | $128.72 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $2,357.35 | 3 |
| PFIZER INC. | $293.09 | 5 |
| Acerta Pharma LLC | $206.44 | 4 |
| Gilead Sciences, Inc. | $164.78 | 2 |
| Daiichi Sankyo Inc. | $155.74 | 4 |
| Janssen Biotech, Inc. | $115.41 | 4 |
| BeiGene USA, Inc. | $99.50 | 4 |
| Genentech USA, Inc. | $91.59 | 3 |
| Adaptive Biotechnologies Corporation | $73.47 | 3 |
| Novocure Inc. | $72.81 | 2 |
| GENZYME CORPORATION | $72.41 | 2 |
| Celgene Corporation | $63.12 | 2 |
| Karyopharm Therapeutics Inc. | $57.04 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.68 | 2 |
| ARRAY BIOPHARMA INC | $43.68 | 2 |
| EISAI INC. | $33.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.34 | 1 |
| Genentech, Inc. | $28.09 | 1 |
| Incyte Corporation | $28.05 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.18 | 1 |
| Merck Sharp & Dohme Corporation | $17.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (50)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.